Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07032792 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Jun 2025 to Nov 3, 2025 · Primary completion date: Jun 2028 to Nov 2028 · Completion date: Jun 2029 to Nov 2029 · 1 morev2 Show 4 more changesShow less
    • Start date changed from estimate of Jun 2025 to Nov 3, 2025
    • Primary completion date: Jun 2028 to Nov 2028
    • Completion date: Jun 2029 to Nov 2029
    • Site details revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Northwell Health
133 trials monitored
See 10 trials at risk
Heart Disease
2,136 trials monitored
See 109 trials at risk
Coagulopathic-induced bleeding after cardiopulmonary bypass in cardiac surgery patients is common and is associated with adverse outcomes in cardiac surgery. The hypothesis of the study is that FEIBA will be a more effective treatment than standard of care (FFP) in cardiac surgery patients who have coagulopathic-induced bleeding. This study is being conducted to determine the efficacy of FEIBA versus FFP as first line therapy in correcting coagulopathic induced microvascular bleeding in cardiac surgery patients.
Trial Details
NCT Number NCT07032792
Lead Sponsor Northwell Health
Conditions Cardiac Disease, Surgery, Bleeding
Enrollment 140 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov